Guardian Pharmacy Services (NYSE:GRDN) Stock Bumped Up to "Buy" by Wall Street Zen

Key Points

• Wall Street Zen upgraded Guardian Pharmacy Services from “hold” to “buy.” The broader analyst consensus is “Moderate Buy,” with nine buy ratings and one hold rating and an average price target of $45.57.
• Guardian reported quarterly EPS of $0.29, exceeding the $0.26 estimate, while revenue of $351.77 million also topped expectations. Analysts project full-year EPS of approximately $1.18.
• Shares opened at $39.34, giving the company a market capitalization of about $1.96 billion; the stock has traded between $23.72 and $48.33 over the past year.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other equities analysts have also commented on the stock. Oppenheimer raised their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a research report on Friday, August 7th. Truist Financial boosted their price objective on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a "buy" rating in a report on Monday, September 21st. KeyCorp started coverage on Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They set an "overweight" rating and a $52.00 target price for the company. Finally, Weiss Ratings upgraded Guardian Pharmacy Services from a "buy (b-)" rating to a "buy (b)" rating in a research report on Thursday, October 8th. Nine equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $45.57.

Guardian Pharmacy Services Stock Down 0.9%

Shares of GRDN opened at $39.34 on Friday. The stock has a market capitalization of $1.96 billion, a P/E ratio of 38.19, a P/E/G ratio of 2.07 and a beta of 0.03. Guardian Pharmacy Services has a twelve month low of $23.72 and a twelve month high of $48.33. The company has a 50 day moving average of $40.83 and a 200-day moving average of $39.87.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. The company had revenue of $351.77 million for the quarter, compared to analysts' expectations of $340.45 million. On average, sell-side analysts anticipate that Guardian Pharmacy Services will post 1.18 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds have recently added to or reduced their stakes in GRDN. State of Alaska Department of Revenue boosted its stake in Guardian Pharmacy Services by 105.9% in the 3rd quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company's stock worth $97,000 after purchasing an additional 1,229 shares during the period. Elevation Point Wealth Partners LLC acquired a new position in shares of Guardian Pharmacy Services in the 1st quarter valued at $253,000. Stephens Inc. AR purchased a new position in shares of Guardian Pharmacy Services during the first quarter worth $282,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Guardian Pharmacy Services in the 2nd quarter valued at about $335,000. Finally, Arizona State Retirement System increased its holdings in Guardian Pharmacy Services by 53.0% in the second quarter. Arizona State Retirement System now owns 8,393 shares of the company's stock valued at $351,000 after buying an additional 2,907 shares during the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc NYSE: GRDN is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company's services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.